U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H31N3O6S2.BrH
Molecular Weight 578.54
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TEBIPENEM PIVOXIL HYDROBROMIDE

SMILES

Br.[H][C@]12[C@@H](C)C(SC3CN(C3)C4=NCCS4)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCOC(=O)C(C)(C)C

InChI

InChIKey=MMWWBQNLJKFAIN-HXLQFWNVSA-N
InChI=1S/C22H31N3O6S2.BrH/c1-11-15-14(12(2)26)18(27)25(15)16(19(28)30-10-31-20(29)22(3,4)5)17(11)33-13-8-24(9-13)21-23-6-7-32-21;/h11-15,26H,6-10H2,1-5H3;1H/t11-,12-,14-,15-;/m1./s1

HIDE SMILES / InChI
Tebipenem pivoxil is an oral carbapenem prodrug that was originated by Wyeth (now Pfizer). It was approved by Pharmaceuticals and Medical Devices Agency of Japan (PMDA) on Apr 22, 2009. It was developed and marketed as Orapenem® by Meiji Seika in Japan. Tebipenem pivoxil is a broad-spectrum orally-administered antibiotic, from the carbapenem subgroup of β-lactam antibiotics. Carbapenems are a class of beta-lactam antibiotics, which act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. It is used to treat otorhinolaryngological infection, otitis media and bacterial pneumonia. Orapenem® is available as granules for oral use, containing 100 mg Tebipenem pivoxil/g granules. According to the weight of children, 4 mg/kg, and twice a day after dinner.

CNS Activity

Curator's Comment: Low penetration to the central nervous system was confirmed in amimal models

Originator

Curator's Comment: # Wyeth (now Pfizer)

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
ORAPENEM

Approved Use

Orapenem is usually used to treat pneumonia, otitis media and sinusitis.

Launch Date

2009
Curative
ORAPENEM

Approved Use

Orapenem is usually used to treat pneumonia, otitis media and sinusitis.

Launch Date

2009
Curative
ORAPENEM

Approved Use

Orapenem is usually used to treat pneumonia, otitis media and sinusitis.

Launch Date

2009
PubMed

PubMed

TitleDatePubMed
Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084.
2006 Apr
[Convulsive liability of an oral carbapenem antibiotic, tebipenem pivoxil].
2009 Jun
Patents

Sample Use Guides

For children: In general, take 0.04 gram per kilogram of body weight (g/kg) (4 mg of the active ingredient [titer]/kg) at a time, twice a day, after meals. The dosage may be increased up to 0.06 g/kg (6 mg [titer]/kg) as needed. Strictly follow the instructions. Standard duration of administration is for 7 days or less. If you miss a dose, take a dose as soon as possible. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time.
Route of Administration: Oral
The MIC90 values of tebipenem pivoxil against Gram-positive bacteria such as methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), methicillin-sensitive Staphylococcus epidermidis (MSSE), methicillin-resistant Staphylococcus epidermidis (MRSE), Pyogenic streptococcus, and Enterococcus faecalis were ≤ 0.125, 16, 0.5, 8, ≤ 0.125, and 32 ug/mL, respectively. Correspondingly, the MIC90 values of tebipenem pivoxil against Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Haemophilus influenzae, Pseudomonas aeruginosa, and Acinetobacter baumannii were 1, 0.5, ≤ 0.125, 0.25, 64, 64 ug/mL, respectively. The MBC values of tebipenem pivoxil against Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae were 0.016-2, 0.063-32, 0.031-32 ug/mL, respectively.
Name Type Language
TEBIPENEM PIVOXIL HYDROBROMIDE
USAN  
Official Name English
SPR-994
Code English
TEBIPENEM PIVOXIL HYDROBROMIDE [USAN]
Common Name English
TBPM-PI-HBR
Code English
1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID, 3-((1-(4,5-DIHYDRO-2-THIAZOLYL)-3-AZETIDINYL)THIO)-6-((1R)-1-HYDROXYETHYL)-4-METHYL-7-OXO-, (2,2-DIMETHYL-1-OXOPROPOXY)METHYL ESTER, HYDROBROMIDE (1:1), (4R,5S,6S)-
Systematic Name English
SPR994
Code English
[(2,2-Dimethylpropanoyl)oxy]methyl (4R,5S,6S)-3-{[1-(4,5-dihydrothiazol-2-yl)azetidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate monohydrobromide
Systematic Name English
Code System Code Type Description
FDA UNII
NT65DX774J
Created by admin on Sat Dec 16 14:15:46 GMT 2023 , Edited by admin on Sat Dec 16 14:15:46 GMT 2023
PRIMARY
USAN
FG-203
Created by admin on Sat Dec 16 14:15:46 GMT 2023 , Edited by admin on Sat Dec 16 14:15:46 GMT 2023
PRIMARY
PUBCHEM
134823893
Created by admin on Sat Dec 16 14:15:46 GMT 2023 , Edited by admin on Sat Dec 16 14:15:46 GMT 2023
PRIMARY
CAS
1381788-20-0
Created by admin on Sat Dec 16 14:15:46 GMT 2023 , Edited by admin on Sat Dec 16 14:15:46 GMT 2023
PRIMARY
SMS_ID
300000011149
Created by admin on Sat Dec 16 14:15:46 GMT 2023 , Edited by admin on Sat Dec 16 14:15:46 GMT 2023
PRIMARY
NCI_THESAURUS
C174765
Created by admin on Sat Dec 16 14:15:46 GMT 2023 , Edited by admin on Sat Dec 16 14:15:46 GMT 2023
PRIMARY